The pre-existing cellular immunity to Japanese encephalitis virus heterotypically protects mice from Zika virus infection
Autor: | Weihong Wang, Hong Tang, Li-Na Shi, Yongfen Xu, Cheng-Feng Qin, Fanfan Zhao, Shengyuan Zhang, Weihong Zhang, Shuru Zhou, Jincun Zhao, Xinwen Lin, Yaling Yang, Marion Tarbe, Jin Zhong, Xiaozhen Liang, Jing Sun, Gang Long, Qibin Leng, Feng Yuan, Shuai Liu, Qiuping Xu, Wei Zhang |
---|---|
Rok vydání: | 2020 |
Předmět: |
education.field_of_study
Cellular immunity Multidisciplinary viruses Population Biology Japanese encephalitis 010502 geochemistry & geophysics Southeast asian biology.organism_classification medicine.disease 01 natural sciences Virology Zika virus Vaccination Immunization medicine Antibody-dependent enhancement education 0105 earth and related environmental sciences |
Zdroj: | Science Bulletin. 65:402-409 |
ISSN: | 2095-9273 |
DOI: | 10.1016/j.scib.2019.11.006 |
Popis: | Zika virus (ZIKV) and Japanese encephalitis virus (JEV) are closely related flaviviruses, ZIKV circulates in the population that has been JEV vaccinated in Southeast Asian countries. This alerts that a pre-existing immunity to JEV would impact ZIKV infection and/or pathogenesis. Herein we showed that the pre-existing immunity to JEV SA14-14-2 vaccination provided an ample protection against non-lethal or lethal dose of ZIKV infection in mice. This was in sharp contrast to the passive immunization of JEV antibodies, which failed to affect ZIKV infection or pathogenesis in mice, albeit these antibodies exhibited cross-reactivity and antibody dependent enhancement (ADE) of ZIKV infection in vitro. Furthermore, we determined that JEV vaccine-elicited CD8+ T cells were required to mediate the heterotypic protection of ZIKV infection, which cross-reacted to ZIKV E and NS5 antigens (E294-302 and NS52839-2848). Adoptive transfer of these CD8+ T cells could partially protect the mice from ZIKV challenge. Therefore, although short of epidemiological evidence, these results suggested that cross-reactive CD8+ T cells activated by JEV vaccination could protect potential ZIKV infection in human populations. |
Databáze: | OpenAIRE |
Externí odkaz: |